Skip to main content
SpringerLink
Log in

Quality of Life in Dermatology

  • Chapter
  • First Online:
Dermatology in Public Health Environments

  • 1491 Accesses

Abstract

Dermatoses may have an important powerful effect on patients’ social, family, and professional life. Besides the objective evaluation of therapeutic results, the influence of diseases on patients’ quality of life, by way of confirmed questionnaires, is also considered relevant, even though the majority of dermatologic patients do not have life-threatening illness but only suffer from the social stigma because of clear evidence of dermatoses. In this context, the formulation of scales measuring the impact of the disease and its treatment is an important reality and helps the physician in the global evaluation of the patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  1. Gill TM, Feinstein AR. A critical appraisal of the quality of quality-of-life measurements. JAMA. 1994;272(8):619–26.

    Article  CAS  PubMed  Google Scholar 

  2. Guyatt GH, Feeny DH, Patrick DL. Measuring health-related quality of life. Ann Intern Med. 1993;118(8):622–9.

    Article  CAS  PubMed  Google Scholar 

  3. The WHOQOL Group. The World Health Organization quality of life assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med. 1995;10:1403–9.

    Google Scholar 

  4. Weber MB, Mazzotti NG, Prati C, Cestari TF. Quality of life assessment in the overall evaluation of dermatology patients. HCPA. 2006;26(2):35–44.

    Google Scholar 

  5. Finlay AY, Khan GK. Dermatology life quality index (DLQI) – a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19:210–6.

    Article  CAS  PubMed  Google Scholar 

  6. Madhulika A, Aditya K. Psychodermatology: an update. J Am Acad Adermatol. 1996;34:1030–46.

    Article  Google Scholar 

  7. Folks DG, Warnock JK. Psycocutaneous disorders. Curr Psychiatry Rep. 2001;3:219–25.

    Article  CAS  PubMed  Google Scholar 

  8. Walker C, Papadopoulos L. Psychodermatology: the psychological impact of skin disorders. New York, Cambridge University Press, 2005. JAMA. 2007;297:97–8.

    Google Scholar 

  9. Tucker P, et al. The psychosocial impact of alopecia areata. J Health Psychol. 2009;14(1):142–51.

    Article  PubMed  Google Scholar 

  10. Manzoni APDS, Weber MB, Nagatomi ARS, Pereira RL, Townsend RZ, Cestari TF. Assessing depression and anxiety in the caregivers of pediatric patients with chronic skin disorders. An Bras Dermatol. 2013;88:894.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Gaspar, Tania et al. Qualidade de vida e bem-estar em crianças e adolescentes. Rev Bras Ter Cogn Dez. 2006;2(2):47–60. ISSN 1808-5687.

    Google Scholar 

  12. Chren MM. Measurement of vital signs for skin diseases. J Invest Dermatol. 2005;125(4):viii–x.

    Article  CAS  PubMed  Google Scholar 

  13. Finlay AY. Quality of life in dermatology: after 125 years, time for more rigorous reporting. Br J Dermatol. 2014;170:4–6. doi:https://doi.org/10.1111/bjd.12737.

    Article  CAS  PubMed  Google Scholar 

  14. Fleck MPA, Leal OF, Louzada S, et al. Desenvolvimento da versão em português do instrumento de avaliação de qualidade de vida da OMS (WHOQOL-100). Rev Bras Psiquiatr. 1999;21(1):19–28.

    Article  Google Scholar 

  15. Development of the World Health Organization WHOQOL-Bref quality of life assessment. The WHOQOL Group. Psychol Med. 1998;28(3):551–8.

    Google Scholar 

  16. Fleck MPA, Louzada S, Xavier M, et al. Aplicação da versão em português do instrumento abreviado de avaliação da qualidade de vida “WHOQOLbref”. Rev Saude Publica. 2000;34(2):178–83.

    Article  CAS  PubMed  Google Scholar 

  17. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol. 1997;136(3):305–14.

    Article  CAS  PubMed  Google Scholar 

  18. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–83.

    Article  PubMed  Google Scholar 

  19. Skoet R, Zachariae R, Agner T. Contact dermatitis and quality of life: a structured review of the literature. Br J Dermatol. 2003;149(3):452–6.

    Article  CAS  PubMed  Google Scholar 

  20. Ciconelli RM, Ferraz MB, Santos W, Meinão I, Quaresma MR. Brazilian-Portuguese version of the SF-36. A reliable and valid quality of life outcome measure. Rev Bras Reumatol. 1999;39(3):143–150., maio-jun.

    Google Scholar 

  21. Lindholm C, Bjellerup M, Christensen OB, Zederfeldt B. Quality of life in chronic leg ulcer patients. An assessment according to the Nottingham health profile. Acta Derm Venereol. 1993;73(6):440–3.

    PubMed  CAS  Google Scholar 

  22. Teixeira-Salmela LF, Magalhães LC, Souza AC, Lima MC, Lima RCM, Goulart F. Adaptação do Perfil de Saúde de Nottingham: um instrumento simples de avaliação da qualidade de vida. Cad Saude Publica. 2004;20(4):905–14.

    Article  PubMed  Google Scholar 

  23. Gilson BS, Gilson JS, Bergner M, et al. The sickness impact profile. Development of an outcome measure of health care. Am J Public Health. 1975;65(12):1304–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Bergner M, Bobbitt RA, Carter WB, Gilson BS. The sickness impact profile: development and final revision of a health status measure. Med Care. 1981;19(8):787–805.

    Article  CAS  PubMed  Google Scholar 

  25. Bergner M, Bobbitt RA, Kressel S, Pollard WE, Gilson BS, Morris JR. The sickness impact profile: conceptual formulation and methodology for the development of a health status measure. Int J Health Serv. 1976;6(3):393–415.

    Article  CAS  PubMed  Google Scholar 

  26. Feio ALJ, Batel Marques FJ, Alexandrino BM, Salek MS. Portuguese cultural adaptation and linguistic validation of Sickness Impact Profile (PSIP). Qual Life Res. 1995;4:424–5.

    Google Scholar 

  27. Finlay AY, Khan GK, Luscombe DK, Salek MS. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol. 1990;123(6):751–6.

    Article  CAS  PubMed  Google Scholar 

  28. Salek MS, Khan GK, Finlay AY. Questionnaire techniques in assessing acne handicap: reliability and validity study. Qual Life Res. 1996;5(1):131–8.

    Article  CAS  PubMed  Google Scholar 

  29. Salek MS, Finlay AY, Luscombe DK, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. Br J Dermatol. 1993;129(4):422–30.

    Article  CAS  PubMed  Google Scholar 

  30. Ruta DA, Garratt AM, Leng M, Russell IT, MacDonald LM. A new approach to the measurement of quality of life. The patient- generated index. Med Care. 1994;32(11):1109–26.

    Article  CAS  PubMed  Google Scholar 

  31. Halioua B, Beumont MG, Lunel F. Quality of life in dermatology. Int J Dermatol. 2000;39(11):801–6.

    Article  CAS  PubMed  Google Scholar 

  32. De Korte J, Mombers FM, Sprangers MA, Bos JD. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol. 2002;138(9):1221–7.

    Article  PubMed  Google Scholar 

  33. Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942–9.

    Article  CAS  PubMed  Google Scholar 

  34. Holme SA, Man I, Sharpe JL, Dykes PJ, Lewis-Jones MS, Finlay AY. The children’s dermatology life quality index: validation of the cartoon version. Br J Dermatol. 2003;148(2):285–90.

    Article  CAS  PubMed  Google Scholar 

  35. Lewis-Jones MS, Finlay AY, Dykes PJ. The infants’ dermatitis quality of life index. Br J Dermatol. 2001;144(1):104–10.

    Article  CAS  PubMed  Google Scholar 

  36. Hahn HB, Melfi CA, Chuang TY, et al. Use of the Dermatology Life Quality Index (DLQI) in a midwestern US urban clinic. J Am Acad Dermatol. 2001;45(1):44–8.

    Article  CAS  PubMed  Google Scholar 

  37. Anderson RT, Rajagopalan R. Development and validation of a quality of life instrument for cutaneous diseases. J Am Acad Dermatol. 1997;37(1):41–50.

    Article  CAS  PubMed  Google Scholar 

  38. Chren MM, Lasek RJ, Quinn LM, Mostow EN, Zyzanski SJ. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107(5):707–13.

    Article  CAS  PubMed  Google Scholar 

  39. Kadyk DL, McCarter K, Achen F, Belsito DV. Quality of life in patients with allergic contact dermatitis. J Am Acad Dermatol. 2003;49(6):1037–48.

    Article  PubMed  Google Scholar 

  40. Kurwa HA, Finlay AY. Dermatology in-patient management greatly improves life quality. Br J Dermatol. 1995;133(4):575–8.

    Article  CAS  PubMed  Google Scholar 

  41. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol. 2000;80(6):430–4.

    Article  CAS  PubMed  Google Scholar 

  42. Mazzotti E, Picardi A, Sampogna F, Sera F, Pasquini P, Abeni D, IDI Multipurpose Psoriasis Research on Vital Experiences Study Group. Sensitivity of the dermatology life quality index to clinical change in patients with psoriasis. Br J Dermatol. 2003;149(2):318–22.

    Article  CAS  PubMed  Google Scholar 

  43. Badia X, Mascaro JM, Lozano R. Measuring health-related quality of life in patients with mild to moderate eczema and psoriasis: clinical validity, reliability and sensitivity to change of the DLQI. The Cavide Research Group. Br J Dermatol. 1999;141(4):698–702.

    Article  CAS  PubMed  Google Scholar 

  44. Kiebert G, Sorensen SV, Revicki D, et al. Atopic dermatitis is associated with a decrement in health related quality of life. Int J Dermatol. 2002;41(3):151–8.

    Article  PubMed  Google Scholar 

  45. Parsad D, Pandhi R, Dogra S, Kanwar AJ, Kumar B. Dermatology life quality index score in vitiligo and its impact on the treatment outcome. Br J Dermatol. 2003;148(2):373–4.

    Article  CAS  PubMed  Google Scholar 

  46. Zachariae R, Zachariae C, Ibsen H, Mortensen JT, Wulf HC. Dermatology life quality index: data from Danish inpatients and outpatients. Acta Derm Venereol. 2000;80(4):272–6.

    Article  CAS  PubMed  Google Scholar 

  47. Harlow D, Poyner T, Finlay AY, Dykes PJ. Impaired quality of life of adults with skin disease in primary care. Br J Dermatol. 2000;143(5):979–82.

    Article  CAS  PubMed  Google Scholar 

  48. Ferraz LB, Almeida FA, Vasconcellos MR, Facina AS, Ciconelli RM, Ferraz MB. The impact of lupus erythematosus cutaneous on the quality of life: the Brazilian-Portuguese version of DLQI. Qual Life Res. 2006;15:565–70.

    Article  CAS  PubMed  Google Scholar 

  49. Lewis V, Finlay AY. 10 years experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc. 2004;9(2):169–80.

    Article  PubMed  Google Scholar 

  50. Loo WJ, Diba V, Chawla M, Finlay AY. Dermatology life quality index: influence of an illustrated version. Br J Dermatol. 2003;148(2):279–84.

    Article  CAS  PubMed  Google Scholar 

  51. Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133(11):1433–40.

    Article  CAS  PubMed  Google Scholar 

  52. Paula HR, Haddad A, Weiss MA, Dini GM, Ferreira LM. Translation, cultural adaptation, and validation of the American Skindex-29 quality of life index. An Bras Dermatol. 2014;89(4):600–7.

    Google Scholar 

  53. Anderson R, Rajagopalan R. Responsiveness of the Dermatology-specific Quality of Life (DSQL) instrument to treatment for acne vulgaris in a placebo-controlled clinical trial. Qual Life Res. 1998;7(8):723–34.

    Article  CAS  PubMed  Google Scholar 

  54. Bech P. Quality of life measurement in the medical setting. Eur Psychiatry. 1995;10:83–5.

    Article  Google Scholar 

  55. Loney T. Psychosocial effects of dermatological-related social anxiety in a sample of acne patients. J Health Psychol. 2008;13(1):47–54.

    Article  PubMed  Google Scholar 

  56. Capoore HS, et al. Does psychological intervention help chronic skin conditions? Postgrad Med J. 1998;74:662–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Lifschitz C. The impact of atopic dermatitis on quality of life. Ann Nutr Metab. 2015;66(Suppl 1):34–40.

    Article  CAS  PubMed  Google Scholar 

  58. Silverberg JI, Silverberg NB. Quality of life impairment in children and adolescents with vitiligo. Pediatr Dermatol. 2014;31(3):309–18.

    Google Scholar 

  59. Eismann EA, Lucky AW, Cornwall R. Hand function and quality of life in children with epidermolysis bullosa. Pediatr Dermatol. 2014;31(2):176–82.

    Article  PubMed  Google Scholar 

  60. Klatchoian DA, et al. Qualidade de vida de crianças e adolescentes de São Paulo: confiabilidade e validade da versão brasileira do questionário genérico Pediatric quality of life inventory TM versão 4.0. J Pediatr. 2008;84(04):308–25.

    Article  Google Scholar 

  61. Scarpelli, Ana C et al. The Pediatric Quality of life inventory™ (PedsQL™) family impact module: reliability and validity of the Brazilian version. Health and Quality of Life Outcomes. 2008;6:35–42.

    Google Scholar 

  62. Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999;37:126–39.

    Article  CAS  PubMed  Google Scholar 

  63. Prati C, Comparin C, Boza JC, Cestari TF. Validação para o português falado no Brasil do instrumento Escore da Qualidade de Vida na Dermatologia Infantil (CDLQI). Med Cutan Iber Lat Am. 2010;38:229–33.

    Google Scholar 

  64. Manificat S, Dazord A. Évaluation de la qualité de vie de l’enfant: validation d’un questionnaire, premiers résultats. Neuropsychiatr Enfance Adolesc. 1997;45:106–14.

    Google Scholar 

  65. Assumpção Jr, Francisco B, Kuczynski E, Sprovieri MH, Aranha EMG. Escala de avaliação de qualidade de vida: (AUQEI – Autoquestionnaire Qualité de Vie Enfant Imagé) validade e confiabilidade de uma escala para qualidade de vida em crianças de 4 a 12 anos. Arq Neuro-Psiquiatr. 2000;58(1):119–27.

    Google Scholar 

  66. Weber MB, Lorenzini D, Reinehr CPH, Lovato B. Assessment of the quality of life of pediatric patients at a center of excellence in dermatology in southern Brazil. An Bras Dermatol. 2012 Oct;87(5):697–702.

    Article  PubMed  Google Scholar 

  67. Shikiar R, Bresnahan BW, Stone SP, Thompson C, Koo J, Revicki DA. Validity and reliability of patient reported outcomes used in psoriasis: results from two randomized clinical trials. Health Qual Life Outcomes. 2003;1(1):53.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Finlay AY, Kelly SE. Psoriasis – an index of disability. Clin Exp Dermatol. 1987;12(1):8–11.

    Article  CAS  PubMed  Google Scholar 

  69. Kent G, al Abadie M. The psoriasis disability index – further analyses. Clin Exp Dermatol. 1993;18(5):414–6.

    Article  CAS  PubMed  Google Scholar 

  70. Gupta MA, Gupta AK. The psoriasis life stress inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol. 1995;75(3):240–3.

    CAS  PubMed  Google Scholar 

  71. McKenna SP, Cook SA, Whalley D, et al. Development of the PSORIQoL, a psoriasis specific measure of quality of life designed for use in clinical practice and trials. Br J Dermatol. 2003;149(2):323–31.

    Article  CAS  PubMed  Google Scholar 

  72. Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140(4):672–6.

    Article  CAS  PubMed  Google Scholar 

  73. Klassen AF, Newton JN, Mallon E. Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures. J Am Acad Dermatol. 2000;43(2 Pt1):229–33.

    Article  CAS  PubMed  Google Scholar 

  74. Oakley AM. The acne disability index: usefulness confirmed. Australas J Dermatol. 1996;37(1):37–9.

    Article  CAS  PubMed  Google Scholar 

  75. Zaraa I, Belghith I, Ben Alaya N, Trojjet S, Mokni M, Ben OA. Severity of acne and its impact on quality of life. Skinmed. 2013;11(3):148–53.

    PubMed  Google Scholar 

  76. Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol. 1989;14(3):194–8.

    Article  CAS  PubMed  Google Scholar 

  77. Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol. 1992;17(1):1–3.

    Article  CAS  PubMed  Google Scholar 

  78. Gupta A, Sharma YK, Dash KN, Chaudhari ND, Jethani S. Quality of life in acne vulgaris: relationship to clinical severity and demographic data. Indian J Dermatol Venereol Leprol. 2016;82(3):292–7.

    Google Scholar 

  79. Martin AR, Lookingbill DP, Botek A, Light J, Thiboutot D, Girman CJ. Health-related quality of life among patients with facial acne – assessment of a new acne-specific questionnaire. Clin Exp Dermatol. 2001;26(5):380–5.

    Article  CAS  PubMed  Google Scholar 

  80. McLeod LD, Fehnel SE, Brandman J, Symonds T. Evaluating minimal clinically important differences for the acne-specific quality of life questionnaire. PharmacoEconomics. 2003;21(15):1069–79.

    Article  PubMed  Google Scholar 

  81. Ladbrooke S, Finch C, Fryatt E, Allgar V, Eady A, Layton A. Twenty years on APSEA still hits the spot: validation of the Assessment of the Psychological and Social Effects of Acne (APSEA) questionnaire in a large cohort of patients with acne. Br J Dermatol. 2015;173(Suppl. S1):21–76.

    Google Scholar 

  82. Fehnel SE, McLeod LD, Brandman J, et al. Responsiveness of the Acne-Specific Quality of Life Questionnaire (Acne-QoL) to treatment for acne vulgaris in placebo-controlled clinical trials. Qual Life Res. 2002;11(8):809–16.

    Article  CAS  PubMed  Google Scholar 

  83. Kent G, al-Abadie M. Factors affecting responses on dermatology life quality index items among vitiligo sufferers. Clin Exp Dermatol. 1996;21(5):330–3.

    Article  CAS  PubMed  Google Scholar 

  84. Balkrishnan R, McMichael AJ, Camacho FT, et al. Development and validation of a health-related quality of life instrument for women with melasma. Br J Dermatol. 2003;149(3):572–7.

    Article  CAS  PubMed  Google Scholar 

  85. Lieu TJ, Pandya AG. Melasma quality of life measures. Dermatol Clin. 2012;30(2):269–280., viii. doi:https://doi.org/10.1016/j.det.2011.11.009.

    Article  CAS  PubMed  Google Scholar 

  86. Cestari TF, Hexsel D, Viegas ML, Azulay L, Hassun K, Almeida ART, Rêgo VRPA, Mendes AMD, Filho JWA, Junqueira H. Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy. Br J Dermatol. 2006;156:13–20.

    Article  PubMed  Google Scholar 

  87. Wallenhammar LM, Nyfjall M, Lindberg M, Meding B. Health-related quality of life and hand eczema – a comparison of two instruments, including factor analysis. J Invest Dermatol. 2004;122(6):1381–9.

    Article  CAS  PubMed  Google Scholar 

  88. Zampieron A, Buja A, Fusco M, Linder D, Bortune M, Piaserico S, Baldo V. Quality of life in patients with scalp psoriasis. G Ital Dermatol Venereol. 2015;150(3):309–16. Epub 2014 Sep 18

    CAS  PubMed  Google Scholar 

  89. Chen SC, Yeung J, Chren MM. Scalpdex: a quality of life instrument for scalp dermatitis. Arch Dermatol. 2002;138(6):803–7.

    Article  PubMed  Google Scholar 

  90. Buske-Kirschbaum A, Geiben A, Hellhammer D. Psychobiological aspects of atopic dermatitis: an overview. Psychother Psychosom. 2001;70(1):6–16.

    Article  CAS  PubMed  Google Scholar 

  91. Rajka G, Langeland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol Suppl (Stockh). 1989;144:13–4.

    CAS  Google Scholar 

  92. Whalley D, McKenna SP, Dewar AL, et al. A new instrument for assessing quality of life in atopic dermatitis: international development of the Quality of Life Index for Atopic Dermatitis (QoLIAD). Br J Dermatol. 2004;150(2):274–83.

    Article  CAS  PubMed  Google Scholar 

  93. Eun H, Finlay AY. Measurement of atopic dermatitis disability. Ann Dermatol. 1990;2:9–12.

    Article  Google Scholar 

  94. Lawson V, Lewis-Jones MS, Finlay AY, Reid P, Owens RG. The family impact of childhood atopic dermatitis: the dermatitis family impact questionnaire. Br J Dermatol. 1998;138:107–13.

    Article  CAS  PubMed  Google Scholar 

  95. Poindexter G, Monthrope Y, Shah N, Chen S. Pruritus quality of life instrument. J Am Acad Dermatol. 2005;52(3 Suppl 1):P106.

    Google Scholar 

  96. Shah N, Palubin K, Lucero M, Chen S. Measuring quality of life impact in patients with pruritus. J Am Acad Dermatol. 2005;52(3 Suppl 1):P105.

    Google Scholar 

  97. Love EM, Marrazzo GA, Kini S, Veledar E, Chen SC. ItchyQoL bands: pilot clinical interpretation of scores. Acta Derm Venereol. 2015;95(1):114–5.

    Article  PubMed  Google Scholar 

  98. Varni JW, Sherman SA, Burwinkle TM, Dickinson PE, Dixon P. The PedsQLTM family impact module: preliminary reliability and validity. Health Qual Life Outcomes. 2004;2:55. doi:https://doi.org/10.1186/1477-7525-2-55.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Scarpelli AC, Paiva SM, Pordeus IA, Varni JW, Viegas CM, Allison PJ. The Pediatric Quality of Life InventoryTM (PedsQLTM) family impact module: reliability and validity of the Brazilian version. Health Qual Life Outcomes. 2008;6:35. doi:https://doi.org/10.1186/1477-7525-6-35.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Basra MKA, Sue-Ho R, Finlay AY. Family dermatology life quality index: measuring the secondary impact of skin disease. Br J Dermatol. 2007;156:528–38. Erratum: Br J Dermatol. 2007;156:791.

    Google Scholar 

  101. Weber MB, Fontes Neto PT, Prati C, Soirefman M, Mazzotti NG, Barzenski B, et al. Improvement of pruritus and quality of life of children with atopic dermatitis and their families after joining support groups. JEADV. 2008;22:992–9.

    PubMed  Google Scholar 

  102. Dodington SR, Basra MK, Finlay AY, Salek MS. The dermatitis family impact questionnaire: a review of its measurement properties and clinical application. Br J Dermatol. 2013;169(1):31–46.

    Article  CAS  PubMed  Google Scholar 

  103. McKenna SP, Whalley D, Dewar AL, Erdman RA, Kohlmann T, Niero M, Baró E, Cook SA, Crickx B, Frech F, van Assche D. International development of the Parents’ Index of Quality of Life in Atopic Dermatitis (PIQoL-AD). Qual Life Res. 2005;14(1):231–41.

    Article  PubMed  Google Scholar 

  104. Chamlin SL, Cella D, Frieden IJ, Williams ML, Mancini AJ, Lai JS, Chren MM. Development of the childhood atopic dermatitis impact scale: initial validation of a quality-of-life measure for young children with atopic dermatitis and their families. J Invest Dermatol. 2005;125:1106–11.

    Article  CAS  PubMed  Google Scholar 

  105. Eghlileb AM, Basra MKA, Finlay AY. The psoriasis family index: preliminary results of validation of a quality of life instrument for family members of patients with psoriasis. Dermatology. 2009;219:63–70.

    Article  CAS  PubMed  Google Scholar 

  106. Catucci BJ, Basra Mohammad KA, Caminha VR, Rosa CR, Blessmann WM, Ferreira CT. Traducao e validacao do instrumento indice de qualidade de vida para familiares de pacientes com psoriase para o portugues falado no Brasil. An Bras Dermatol. 2013;88(3):488–9.

    Google Scholar 

  107. Lewis-Jones MS, Dawe RS, Lowe JG. Quality of life in children with type 1 latex allergy and their parents: use and primary validation of the QoLLAC and QoLLA-P questionnaires. Br J Dermatol. 2005;153(Suppl 1):83–4.

    Google Scholar 

  108. Boza JC, Kundu RV, Fabbrin A, Horn R, Giongo N, Cestari TF. Tradução, adaptação cultural e validação do instrumento de avaliação da qualidade de vida de pacientes com vitiligo (VitiQol) para o Português falado no Brasil. An Bras Dermatol. 2015;90(3):355–60.

    Article  Google Scholar 

  109. Alvarenga Tassiana MM, Caldeira Antônio P. Qualidade de vida em pacientes pediátricos com dermatite atópica. J Pediatr. 2009;85(5):415–20.

    Google Scholar 

  110. Şenol A, Yücelten AD, Ay P. Development of a quality of life scale for vitiligo. Dermatology. 2013;226(2):185–90. doi:https://doi.org/10.1159/000348466. Epub 2013 May 28

    Article  PubMed  Google Scholar 

  111. Lilly E, Lu PD, Borovicka JH, Victorson D, Kwasny MJ, West DP, Kundu RV. Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol. 2013;69(1):e11–8. doi:https://doi.org/10.1016/j.jaad.2012.01.038. Epub 2012 Feb 25

    Article  PubMed  Google Scholar 

  112. Gupta V, Sreenivas V, Mehta M, Khaitan BK, Ramam M. Measurement properties of the vitiligo impact scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument. Br J Dermatol. 2014;171:1084–90.

    Article  CAS  PubMed  Google Scholar 

  113. Cardiff’s Department of Dermatology [homepage]. Quality of life questionnaires. Available in: http://sites.cardiff.ac.uk/dermatology/quality-of-life/.

Download references

Author information

Authors and Affiliations

  1. Dermatology Service of Federal University of Health Sciences of Porto Alegre, Porto Alegre, Brazil

    Magda Blessmann Weber, Mariele Bevilaqua & Rebeca Kollar Vieira da Silva

Authors
  1. Magda Blessmann Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mariele Bevilaqua
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rebeca Kollar Vieira da Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Magda Blessmann Weber .

Editor information

Editors and Affiliations

  1. Dermatology Service of Clinical, Hospital of Porto Alegre, Federal University of Rio Grande do Sul, Porto Alegre, Brazil

    Renan Rangel Bonamigo

  2. Health Secretary of Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil

    Sergio Ivan Torres Dornelles

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing Switzerland

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Weber, M.B., Bevilaqua, M., da Silva, R.K.V. (2018). Quality of Life in Dermatology. In: Bonamigo, R., Dornelles, S. (eds) Dermatology in Public Health Environments. Springer, Cham. https://doi.org/10.1007/978-3-319-33919-1_55

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-33919-1_55

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-33917-7

  • Online ISBN: 978-3-319-33919-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation